An international comparison of spontaneous adverse event reports and potentially inappropriate medicine use associated with dabigatran-Reference-Cited by-同舟云学术

An international comparison of spontaneous adverse event reports and potentially inappropriate medicine use associated with dabigatran

Published:2014-05-20 Issue:4 Volume:24 Page:399-405
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

McDonald Cameron J.¹,Kalisch Ellett Lisa M.¹,Barratt John D.¹,Caughey Gillian E.¹

Affiliation:

1. Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, School of Pharmacy and Medical Sciences; University of South Australia; Adelaide Australia

Funder

Australian Government National Health and Medical Research Council Centre of Research Excellence in Post-Marketing Surveillance of Medicines and Medical Devices Grant

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference22 articles.

1. Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review;Adam;Ann Intern Med,2012

2. A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran;Sipahi;JAMA Intern Med,2013

3. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (randomized evaluation of long-term anticoagulation therapy) trial;Hohnloser;Circulation,2012

4. The use of dabigatran in elderly patients;Legrand;Arch Intern Med,2011

5. Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism;Granger;Circulation,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) do not Increase the Risk of Hepatic Impairment in Patients with Non-Valvular Atrial Fibrillation: Insights from Multi-Source Medical Data;Reviews in Cardiovascular Medicine;2022-03-12

2. Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database;Journal of Clinical Pharmacy and Therapeutics;2021-03

3. Drug interactions of direct oral anticoagulants in elderly patients with cardiometabolic diseases;Current Research in Pharmacology and Drug Discovery;2021

4. The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis;International Journal of Environmental Research and Public Health;2020-12-27

5. Spontaneous reports of adverse drug reactions related to oral anticoagulants in the Czech Republic;International Journal of Clinical Pharmacy;2020-11-27